These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Prognosis
10 results:

  • 1. KLF7 promotes colon adenocarcinoma progression through the pdgfb signaling pathway.
    Zhang Z; Jiang X; Li K; Qiao S; Li M; Mei Y; Ding L; Lv Q; Ding Y; Zhao Y; Lv G; Tan G; Yang H; Li G; Gao X; Liu M
    Int J Biol Sci; 2024; 20(1):387-402. PubMed ID: 38164176
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mutation Profile via Next-Generation Sequencing in Patients with colorectal Adenocarcinoma and Its Clinicopathological Correlation.
    Osman S; Kahraman Çetin N; Erdoğdu İH; Meteoğlu İ
    Turk J Gastroenterol; 2023 Nov; 34(11):1124-1133. PubMed ID: 37737217
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Inflammation-Related Biomarkers for the Prediction of Prognosis in colorectal cancer Patients.
    Yamamoto T; Kawada K; Obama K
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360768
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A 10-gene-methylation-based signature for prognosis prediction of colorectal cancer.
    Li DH; Du XH; Liu M; Zhang R
    Cancer Genet; 2021 Apr; 252-253():80-86. PubMed ID: 33444882
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer.
    Schölch S; Bogner A; Bork U; Rahbari M; Győrffy B; Schneider M; Reissfelder C; Weitz J; Rahbari NN
    Sci Rep; 2019 Jul; 9(1):10921. PubMed ID: 31358848
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CT Staging to Triage Selection of Patients With Poor-Prognosis Rectal cancer for Neoadjuvant Treatment.
    Ortega CD; Rocha MS
    AJR Am J Roentgenol; 2019 Aug; 213(2):358-364. PubMed ID: 30995084
    [No Abstract]    [Full Text] [Related]  

  • 7. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas.
    Ishihama K; Yamakawa M; Semba S; Takeda H; Kawata S; Kimura S; Kimura W
    J Clin Pathol; 2007 Nov; 60(11):1205-10. PubMed ID: 17720775
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Effect of the farnesyl transferase inhibitor L-744,832 on the colon cancer cell line DLD-1 and its combined use with radiation and 5-FU.
    Kavgaci H; Ozdemir F; Ovali E; Yavuz A; Yavuz M; Aydin F
    Chemotherapy; 2005 Oct; 51(6):319-23. PubMed ID: 16224182
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis.
    Handa K; Yamakawa M; Takeda H; Kimura S; Takahashi T
    Int J Cancer; 1999 Jun; 84(3):225-33. PubMed ID: 10371338
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. colorectal carcinoma in different age groups: a population-based investigation.
    Fante R; Benatti P; di Gregorio C; De Pietri S; Pedroni M; Tamassia MG; Percesepe A; Rossi G; Losi L; Roncucci L; Ponz de Leon M
    Am J Gastroenterol; 1997 Sep; 92(9):1505-9. PubMed ID: 9317073
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.